Copyright
©2010 Baishideng.
World J Gastroenterol. Jan 14, 2010; 16(2): 143-155
Published online Jan 14, 2010. doi: 10.3748/wjg.v16.i2.143
Published online Jan 14, 2010. doi: 10.3748/wjg.v16.i2.143
Table 3 Prevalence of thrombotic risk factors in series of routinely investigated, consecutive adult patients with non tumorous and non cirrhotic, acute or chronic, PVT[126]
| Risk factor | PVT patients (%) |
| Myeloproliferative disorders | 30-40 |
| Atypical | 14 |
| Classical | 17 |
| Antithrombin deficiency | 0-26 |
| Protein C deficiency | 0-26 |
| Protein S deficiency | 2-30 |
| Factor V Leiden mutation | 6-32 |
| Prothrombine mutation | 14-40 |
| TT677 methylene tetrahydrofolate reductase (MTHFR) genotype | 11-50 |
| Antiphospholipid syndrome | 6-19 |
| Hyperomocisteinemia | 12-22 |
| Recent pregnancy | 6-40 |
| Recent oral contraceptive use | 12 |
- Citation: Ponziani FR, Zocco MA, Campanale C, Rinninella E, Tortora A, Maurizio LD, Bombardieri G, Cristofaro RD, Gaetano AMD, Landolfi R, Gasbarrini A. Portal vein thrombosis: Insight into physiopathology, diagnosis, and treatment. World J Gastroenterol 2010; 16(2): 143-155
- URL: https://www.wjgnet.com/1007-9327/full/v16/i2/143.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i2.143